New Key Statistics Module, Z-Score and F-Score
SHSE:600521 Key Ratios
Market Cap ¥ M | 24,964.18 |
Enterprise Value ¥ M | 30,338.20 |
P/E(ttm) | 26.59 |
PE Ratio without NRI | 22.85 |
Forward PE Ratio | 20.75 |
Price/Book | 3.03 |
Price/Sales | 2.81 |
Price/Free Cash Flow | 21.73 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.32 |
Revenue (TTM) ¥ M | 8,748.00 |
EPS (TTM) ¥ | 0.64 |
Beneish M-Score | -2.99 |
10-y EBITDA Growth Rate % | 15.10 |
5-y EBITDA Growth Rate % | 21.20 |
y-y EBITDA Growth Rate % | -16.20 |
EV-to-EBIT | 20.78 |
EV-to-EBITDA | 20.78 |
PEG | 1.08 |
Shares Outstanding M | 1,466.76 |
Net Margin (%) | 10.61 |
Operating Margin % | 18.87 |
Pre-tax Margin (%) | 14.07 |
Quick Ratio | 0.85 |
Current Ratio | 1.33 |
ROA % (ttm) | 4.87 |
ROE % (ttm) | 11.47 |
ROIC % (ttm) | 8.27 |
Dividend Yield % | 1.18 |
Altman Z-Score | 2.45 |
SHSE:600521 Number of Guru Trades
SHSE:600521 Volume of Guru Trades
Gurus Latest Trades with SHSE:600521
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:600521 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Huahai Pharmaceutical Co Ltd Insider Transactions
No Available Data